241 related articles for article (PubMed ID: 15756441)
1. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract][Full Text] [Related]
2. Disordered expression of HOX genes in human non-small cell lung cancer.
Abe M; Hamada J; Takahashi O; Takahashi Y; Tada M; Miyamoto M; Morikawa T; Kondo S; Moriuchi T
Oncol Rep; 2006 Apr; 15(4):797-802. PubMed ID: 16525661
[TBL] [Abstract][Full Text] [Related]
3. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.
Takahashi O; Hamada J; Abe M; Hata S; Asano T; Takahashi Y; Tada M; Miyamoto M; Kondo S; Moriuchi T
Oncol Rep; 2007 Apr; 17(4):753-60. PubMed ID: 17342311
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas.
Kanai M; Hamada J; Takada M; Asano T; Murakawa K; Takahashi Y; Murai T; Tada M; Miyamoto M; Kondo S; Moriuchi T
Oncol Rep; 2010 Mar; 23(3):843-51. PubMed ID: 20127028
[TBL] [Abstract][Full Text] [Related]
6. Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells.
Yamashita T; Tazawa S; Yawei Z; Katayama H; Kato Y; Nishiwaki K; Yokohama Y; Ishikawa M
Int J Oncol; 2006 Apr; 28(4):931-8. PubMed ID: 16525643
[TBL] [Abstract][Full Text] [Related]
7. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mRNA for HOX gene in human breast cancer and non-cancerous tissues].
Makiyama K
Hokkaido Igaku Zasshi; 2004 Nov; 79(6):719-26. PubMed ID: 15675302
[No Abstract] [Full Text] [Related]
9. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
10. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
12. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis.
Stringer BK; Cooper AG; Shepard SB
Cancer Res; 2001 Jan; 61(2):582-8. PubMed ID: 11212253
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes.
Abdel-Fattah R; Xiao A; Bomgardner D; Pease CS; Lopes MB; Hussaini IM
J Pathol; 2006 May; 209(1):15-24. PubMed ID: 16463268
[TBL] [Abstract][Full Text] [Related]
16. Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma.
Chen KN; Gu ZD; Ke Y; Li JY; Shi XT; Xu GW
Clin Cancer Res; 2005 Feb; 11(3):1044-9. PubMed ID: 15709170
[TBL] [Abstract][Full Text] [Related]
17. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer.
Zhao Y; Yamashita T; Ishikawa M
Oncol Rep; 2005 Apr; 13(4):721-6. PubMed ID: 15756448
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
Yamasaki T; Tsuda H; Imazeki N; Matsubara O
Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
